C-type natriuretic peptide-modified lipid vesicles: fabrication and use for the treatment of brain glioma.

about

C-type natriuretic peptide-modified lipid vesicles: fabrication and use for the treatment of brain glioma.

Item

http://www.wikidata.org/entity/Q41093388

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

C-type natriuretic peptide-mod ...... the treatment of brain glioma.

@en

type

Item

label

C-type natriuretic peptide-mod ...... the treatment of brain glioma.

@en

prefLabel

C-type natriuretic peptide-mod ...... the treatment of brain glioma.

@en

P1476

C-type natriuretic peptide-mod ...... the treatment of brain glioma.

@en

P2093

Jia-Shuan Wu

http://www.w3.org/2001/XMLSchema#string

Jing Bai

http://www.w3.org/2001/XMLSchema#string

Jing-Ying Zhang

http://www.w3.org/2001/XMLSchema#string

Lei Liu

http://www.w3.org/2001/XMLSchema#string

Li-Min Mu

http://www.w3.org/2001/XMLSchema#string

Wan-Liang Lu

http://www.w3.org/2001/XMLSchema#string

Weiyue Lu

http://www.w3.org/2001/XMLSchema#string

Yan Yan

http://www.w3.org/2001/XMLSchema#string

Ying-Jie Hu

http://www.w3.org/2001/XMLSchema#string

Ying-Zi Bu

http://www.w3.org/2001/XMLSchema#string

P2860

Innate immunity in the CNS: redefining the relationship between the CNS and Its environment

Brain barriers: Crosstalk between complex tight junctions and adherens junctions

CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012.

Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery.

Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma

Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial.

Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: a hellenic cooperative oncology group clinical translational study.

Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution

Natriuretic peptide clearance receptor ligand (C-ANP4-23 ) attenuates angiogenesis in a murine sponge implant model.

Bacterial induction of Snail1 contributes to blood-brain barrier disruption.

P304

40906-40921

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.16641

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28402948

http://www.w3.org/2001/XMLSchema#string

P921

C-Type natriuretic peptide

P932

5522305

http://www.w3.org/2001/XMLSchema#string